Avantor, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Avantor, Inc. (AVTR) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$26.80 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-04-29
- Avantor, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$26.80M, a 140.42% decline year-over-year.
- Avantor, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $6.70M.
- Avantor, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$13.20M, a 139.52% decline year-over-year.
- Avantor, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was $107.30M.
- Avantor, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $167.10M.
- Avantor, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$115.00M, a 467.41% decline from fiscal 2023.
- Avantor, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $31.30M.
- Avantor, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$57.10M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$26.80M 10-Q · filed 2026-04-29 | -$20.10M derived: sum of 2 quarters · filed 2026-04-29 | -$33.30M derived: sum of 3 quarters · filed 2026-04-29 | $74.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$6.50M derived: sum of 2 quarters · filed 2026-02-11 | $100.80M derived: sum of 3 quarters · filed 2026-02-11 | $167.10M 10-K · filed 2026-02-11 |
| 2025-09-30 | -$13.20M 10-Q · filed 2025-10-29 | $94.10M derived: sum of 2 quarters · filed 2025-10-29 | $160.40M 10-Q · filed 2025-10-29 | $50.30M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $107.30M 10-Q · filed 2025-08-01 | $173.60M 10-Q · filed 2025-08-01 | $63.50M derived: sum of 3 quarters · filed 2026-04-29 | $96.90M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $66.30M 10-Q · filed 2026-04-29 | -$43.80M derived: sum of 2 quarters · filed 2026-04-29 | -$10.40M derived: sum of 3 quarters · filed 2026-04-29 | -$20.70M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$110.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$76.70M derived: sum of 2 quarters · filed 2026-02-11 | -$87.00M derived: sum of 3 quarters · filed 2026-02-11 | -$115.00M 10-K · filed 2026-02-11 |
| 2024-09-30 | $33.40M 10-Q · filed 2025-10-29 | $23.10M derived: sum of 2 quarters · filed 2025-10-29 | -$4.90M 10-Q · filed 2025-10-29 | $37.20M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -$10.30M 10-Q · filed 2025-08-01 | -$38.30M 10-Q · filed 2025-08-01 | $3.80M derived: sum of 3 quarters · filed 2026-02-11 | -$35.40M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -$28.00M 10-Q · filed 2025-04-25 | $14.10M derived: sum of 2 quarters · filed 2026-02-11 | -$25.10M derived: sum of 3 quarters · filed 2026-02-11 | -$7.30M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $42.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $2.90M derived: sum of 2 quarters · filed 2026-02-11 | $20.70M derived: sum of 3 quarters · filed 2026-02-11 | $31.30M 10-K · filed 2026-02-11 |
| 2023-09-30 | -$39.20M 10-Q · filed 2024-10-25 | -$21.40M derived: sum of 2 quarters · filed 2024-10-25 | -$10.80M 10-Q · filed 2024-10-25 | $100.70M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $17.80M 10-Q · filed 2024-07-26 | $28.40M 10-Q · filed 2024-07-26 | $139.90M derived: sum of 3 quarters · filed 2025-02-07 | $76.40M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $10.60M 10-Q · filed 2024-04-26 | $122.10M derived: sum of 2 quarters · filed 2025-02-07 | $58.60M derived: sum of 3 quarters · filed 2025-02-07 | -$20.40M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $111.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $48.00M derived: sum of 2 quarters · filed 2025-02-07 | -$31.00M derived: sum of 3 quarters · filed 2025-02-07 | -$57.10M 10-K · filed 2025-02-07 |
| 2022-09-30 | -$63.50M 10-Q · filed 2023-10-27 | -$142.50M derived: sum of 2 quarters · filed 2023-10-27 | -$168.60M 10-Q · filed 2023-10-27 | -$173.70M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$79.00M 10-Q · filed 2023-07-28 | -$105.10M 10-Q · filed 2023-07-28 | -$110.20M derived: sum of 3 quarters · filed 2024-02-14 | -$149.70M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | -$26.10M 10-Q · filed 2023-04-28 | -$31.20M derived: sum of 2 quarters · filed 2024-02-14 | -$70.70M derived: sum of 3 quarters · filed 2024-02-14 | -$53.20M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | -$5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$44.60M derived: sum of 2 quarters · filed 2024-02-14 | -$27.10M derived: sum of 3 quarters · filed 2024-02-14 | -$64.90M 10-K · filed 2024-02-14 |
| 2021-09-30 | -$39.50M 10-Q · filed 2022-10-28 | -$22.00M derived: sum of 2 quarters · filed 2022-10-28 | -$59.80M 10-Q · filed 2022-10-28 | $16.60M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $17.50M 10-Q · filed 2022-07-29 | -$20.30M 10-Q · filed 2022-07-29 | $56.10M derived: sum of 3 quarters · filed 2023-02-14 | $110.20M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$37.80M 10-Q · filed 2022-04-29 | $38.60M derived: sum of 2 quarters · filed 2023-02-14 | $92.70M derived: sum of 3 quarters · filed 2023-02-14 | $137.20M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $76.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $130.50M derived: sum of 2 quarters · filed 2023-02-14 | $175.00M derived: sum of 3 quarters · filed 2023-02-14 | $107.60M 10-K · filed 2023-02-14 |
| 2020-09-30 | $54.10M 10-Q · filed 2021-10-29 | $98.60M derived: sum of 2 quarters · filed 2021-10-29 | $31.20M 10-Q · filed 2021-10-29 | $72.80M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $44.50M 10-Q · filed 2021-07-30 | -$22.90M 10-Q · filed 2021-07-30 | $18.70M derived: sum of 3 quarters · filed 2022-02-11 | -$44.10M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | -$67.40M 10-Q · filed 2021-04-28 | -$25.80M derived: sum of 2 quarters · filed 2022-02-11 | -$88.60M derived: sum of 3 quarters · filed 2022-02-11 | -$77.20M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $41.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | -$21.20M derived: sum of 2 quarters · filed 2022-02-11 | -$9.80M derived: sum of 3 quarters · filed 2022-02-11 | -$19.40M 10-K · filed 2022-02-11 |
| 2019-09-30 | -$62.80M 10-Q · filed 2020-10-27 | -$51.40M derived: sum of 2 quarters · filed 2020-10-27 | -$61.00M 10-Q · filed 2020-10-27 | -$94.40M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $11.40M 10-Q · filed 2020-07-29 | $1.80M 10-Q · filed 2020-07-29 | -$31.60M derived: sum of 3 quarters · filed 2021-02-16 | -$33.20M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | -$9.60M 10-Q · filed 2020-04-29 | -$43.00M derived: sum of 2 quarters · filed 2021-02-16 | -$44.60M derived: sum of 3 quarters · filed 2021-02-16 | -$130.80M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | -$33.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$35.00M derived: sum of 2 quarters · filed 2021-02-16 | -$121.20M derived: sum of 3 quarters · filed 2021-02-16 | -$92.90M 10-K · filed 2021-02-16 |
| 2018-09-30 | -$1.60M 10-Q · filed 2019-11-05 | -$87.80M derived: sum of 2 quarters · filed 2019-11-05 | -$59.50M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | -$86.20M 10-Q · filed 2019-08-06 | -$57.90M 10-Q · filed 2019-08-06 | ||
| 2017-12-31 | $70.50M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |